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Late neonatal varicella
on injection acyclovir at a dose of 10 mg/kg/dose 8 hourly along with strict maintenance of hygiene. She showed crusting and substantial reduction of skin lesions by day 19 of her life [ Figure 1b ] and was discharged on exclusive breast feeds on day 21 after 7 days of intravenous acyclovir therapy.
Neonatal varicella occurs in babies of mothers who develop chickenpox during the last 3 weeks of pregnancy; the infection is usually transmitted from the mother to child by transplacental route, ascending infection during delivery, or by postnatal contact (respiratory droplet/direct). [1] The presentation of neonatal varicella depends on the time of maternal infection. If the mother develops rash on day 5 antepartum to day 2 postpartum, generalized neonatal varicella leading to death occurs in approximately one-fifth of cases. Neonatal chickenpox within the first 4 days after birth is usually mild. A fatal outcome has been reported in 23% of cases if neonatal chickenpox occurs between 5 and 10-12 days of age. If mother is symptomatic within 5 days before to 2 days after delivery, there is no time for transfer of varicella-associated antibody to the baby; thus, the baby has severe infection and usually it is fatal. If the mother has symptoms at least 5 days before delivery, the disease in infants is attenuated, as adequate maternal antibodies are transferred to the fetus. [1] Although, in our case, the mother was Sir, A 14-day-old newborn female baby was admitted with complaints of generalized polymorphic rashes over body for 3 days [ Figure 1a ]. She was born by normal vaginal delivery at home to a 30-year-old, second gravida mother at term gestation. The mother developed similar lesions 1 day before onset of labor. There was history of contact with her sister-in-law having similar illness. At presentation, the baby weighed 3.1 kg and had stable vital parameters. A clinical diagnosis of neonatal varicella was made and the baby was started symptomatic 1 day before delivery and the baby did not receive varicella zoster immunoglobulin (VZV), fortunately, the baby did not have any of severe manifestations such as pneumonia, hepatitis, or encephalitis. Early and appropriate institution of therapy may have also helped in the same. This is of particular interest in a country like India, where most, if not all such babies with risk for severe neonatal varicella do not receive VZV in view of nonavailability and high cost.
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